ENDPOINTS NEWS
Endpoints News is an independent news organization that analyzes and reports the top global biotech & pharmaceutical R&D news.
ENDPOINTS NEWS
Industry:
Information Services News Publishing
Founded:
2014-01-01
Address:
Lawrence, Kansas, United States
Country:
United States
Website Url:
http://www.endpts.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Similar Organizations
Automotive News
Automotive News focuses on providing news and information related to the automotive industry.
TheStreet
TheStreet, a digital financial media company, offers content and tools through a range of online, social media, tablet and mobile channels.
Current Employees Featured
Founder
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-14 | Endpoints News Appoints Healthcare Executive Chip Staton as Chief Financial Officer |
Official Site Inspections
http://www.endpts.com Semrush global rank: 246.08 K Semrush visits lastest month: 284.17 K
- Host name: server-13-32-87-63.mia3.r.cloudfront.net
- IP address: 13.32.87.63
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Endpoints News"
Frequently Asked Questions – Endpoints News - endpts.com
Once activated, everyone at your organization can access premium content using their organization-issued email — no individual subscription management required. Request a …See details»
@endpts.com on Bluesky - bsky.app
Profile. Endpoints News. endpts.com. did:plc:l5aan5lkmuqstilgyczaho3v. We're where the business of medicine gets answers. An independent news media organization covering …See details»
From the founders: Endpoints is now part of the …
Apr 3, 2023 Dear Endpoints Readers, We’d like to tell you about a partnership we’ve struck with the Financial Times that will take our news organization to the next stage of its exciting ...See details»
Endpoints News - LinkedIn
Endpoints News | 20,915 followers on LinkedIn. The biopharma world is here | Endpoints is the biopharma world's leading source for breaking news, smart analysis and exclusive access. We cover the ...See details»
Endpoints Webinars
Where does your organization sit on the omnichannel maturity curve? sponsored by Syneos Health. watch Now. Flattening the 'valley of death:' New tools in the hunt for better preclinical R&D. organized by Endpoints News. watch Now. …See details»
Save the Date: Endpoints 11 Returns in 2025 - events.endpts.com
The future of biotech is taking shape—be there to see it happen. Endpoints 11 returns in 2025, spotlighting the 11 most promising biotechs redefining drug development. Join us in Downtown …See details»
Endpoints | FT Specialist - Specialist insight from the …
Get the most comprehensive coverage of the biotech and pharmaceutical industries, with exclusive reporting, real-time coverage on the biggest stories, and top-notch science and business journalism; Breaking news alerts delivered to …See details»
State of the union for advanced medicines - Endpoints …
Regenerative medicines are evolving at breakneck speed—and every advance has far-reaching implications. To be effective in CGTx development, you also need to understand the current investment landscape, new and exciting …See details»
The R&D 15 - events.endpts.com
Apr 1, 2025 For well over 15 years Endpoints founding editor John Carroll has written an annual report on the top 15 global pharma companies’ R&D budgets, analyzing their pipelines and …See details»
Planning for CGT commercialization: It starts sooner …
Every decision throughout cell and gene therapy preclinical development is an opportunity to set the stage for future commercial success. From anticipating supply needs to planning ahead for commercial scale-up, what are the major …See details»
Paid subscription terms and conditions – Endpoints News
Nov 24, 2023 About these Terms. We are Endpoints News Media Company, LLC whose principal place of business is 2029 Becker Drive, Lawrence, KS 66047, USA. If you need …See details»
Endpoints Cell & Gene Therapy Day | May 11, 2023
The future is now: CGTx innovation, challenges, and perspectives. Despite recent economic challenges, innovators are working tirelessly to develop cutting-edge advancements that have …See details»
Endpoints at #ESMO24
Sep 17, 2024 ESMO is the oncology conference to watch this year — the Endpoints team is on the ground reporting on the latest readouts and pipeline updates from the European cancer …See details»
The Endpoints 100 survey: What are biopharma execs saying …
Dec 11, 2024 We’ve asked our advisory group in the E100 about how things are shaping up at the FDA and HHS under the new Trump administration and what impact prospective changes …See details»
Decentralized trial solutions for complex clinical trials
Improving the patient experience while overcoming DCT challenges for a pediatric rare disease population Making decentralized clinical trials a successful reality for the most complex studies …See details»
Introducing the new Endpoints profile experience - endpts.com
3 days ago Endpoints platform launches new profile system with improved account management features, including streamlined newsletter selection and enhanced security options.See details»
Endpoints at #JPM22 - A look at what's to come in 2022
A look at what's to come in 2022 Jan 10 through Jan 12 virtual event. The biopharma world kicks off each year with a frenzy of activity at JP Morgan. Endpoints has been there to chronicle it …See details»
After a decade of consolidation, who rules the CRO roost?
Cynthia Verst President, Design & Delivery Innovation, R&D Solutions, IQVIA. Cyndi is a proven leader with over 25 years of clinical development and real-word research, payer and provider …See details»
Endpoints 11 - Biopharma's Most Promising Startups in 2021
The biotech 2.0 era has arrived. And with that backdrop, we'll unveil the top 11 companies supercharging a new generation of startups in 2021.See details»
The 20(+2) under 40: Your guide to the next generation of biotech …
May 24, 2023 The 20(+2) under 40: Your guide to the next generation of biotech leadersSee details»